tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Financial Statements

170 Followers

Rallybio Financial Overview

Rallybio's market cap is currently ―. The company's EPS TTM is $-1.843; its P/E ratio is -0.86; Rallybio is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -19.63M$ -17.73M$ -18.41M$ -18.30M$ -17.06M
EBITDA$ -20.25M-$ -19.21M$ -19.16M$ -17.48M
Net Income Common Stockholders$ -20.25M$ -18.31M$ -18.63M$ -17.16M$ -15.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 109.93M$ 121.38M$ 137.84M$ 150.39M$ 168.99M
Total Assets$ 115.62M$ 133.19M$ 147.58M$ 161.97M$ 180.44M
Total Debt$ 392.00K$ 428.00K$ 479.00K$ 518.00K$ 555.00K
Net Debt$ -109.54M$ -120.96M$ -137.36M$ -149.87M$ -168.44M
Total Liabilities$ 9.44M$ 9.61M$ 8.32M$ 7.12M$ 11.12M
Stockholders Equity$ 106.18M$ 123.58M$ 139.26M$ 155.20M$ 169.32M
Cash Flow-
Free Cash Flow$ -11.66M-$ -13.38M$ -18.77M$ -15.26M
Operating Cash Flow$ -11.64M$ -16.47M$ -13.38M$ -18.77M$ -15.26M
Investing Cash Flow$ 16.91M$ 3.07M$ 6.21M$ 1.47M$ -30.65M
Financing Cash Flow$ 72.00K-$ 210.00K$ -139.00K$ 51.16M
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis